1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia

Technology appraisal guidance [TA426] Published: 21 December 2016

  • Guidance
  • Tools and resources
  • Information for the public
  • History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance